Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery
Not Applicable
Completed
- Conditions
- Crohn Disease in Remission
- Registration Number
- NCT05214430
- Lead Sponsor
- Jinling Hospital, China
- Brief Summary
For patients with Crohn's diseases undergoing surgery，whether postoperative exclusive enteral nutrition(EEN) could delay the endoscopic relapse needs exploration.The trial will investigate the efficacy of postoperative EEN for maintaining disease remission.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
- CD patients who undergoing bowel resection with anastomosis
Exclusion Criteria
- patients who received stoma creation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method postoperative endoscopic recurrence 1 YEAR over i2b of rutgeerts score
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of exclusive enteral nutrition in postoperative Crohn's disease remission?
How does postoperative exclusive enteral nutrition compare to corticosteroids in maintaining Crohn's disease remission?
Which biomarkers predict response to exclusive enteral nutrition in postoperative Crohn's patients?
What are the potential adverse events associated with 3-month postoperative exclusive enteral nutrition regimens?
Are there combination therapies with exclusive enteral nutrition for Crohn's disease post-surgery?
Trial Locations
- Locations (1)
General Surgery Institute,Jinling Hospital,Nanjing,Jiangsu,China
🇨🇳Nanjing, Jiangsu, China
General Surgery Institute,Jinling Hospital,Nanjing,Jiangsu,China🇨🇳Nanjing, Jiangsu, China